You are here: Industry Insights > study

News List

Emmaus Life Sciences Announces Study Protocol for Pharmaceutical-grade L-glutamine americanpharmaceuticalreview
June 26, 2019
Emmaus Life Sciences has announced the use of its pharmaceutical-grade L-glutamine (PGLG) in a clinical study to determine its efficacy in lowering blood sugar in patients with type II diabetes.
Oral Novo Nordisk diabetes drug poses no more heart risk than placebo: study expressbpd
June 14, 2019
Patients with type 2 diabetics and either heart disease who received the drug semaglutide in pill form had a combined rate of heart attack, stroke or heart-related death of 3.8 per cent compared with 4.8 per cent for placebo
IMPALA Phase 3 Study of Molgradex Does Not Meet Primary Endpoint americanpharmaceuticalreview
June 14, 2019
Savara announced top line data from IMPALA, a pivotal Phase 3 clinical study evaluating Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF), for the treatment of aPAP ...
Study Shows Dapagliflozin Reduces Kidney Disease Progression, Renal Death in T2D Patients americanpharmaceuticalreview
June 13, 2019
The first sub-analysis of renal data from the Dapagliflozin Effect on Cardiovascular Events Thrombolysis In Myocardial Infarction (DECLARE-TIMI 58) trial indicates that dapagliflozin, an oral sodium glucose cotransporter 2 (SGLT2) inhibitor ...
Windtree, Eleison Announce Study Results of Delivering Inhaled Lipid Cisplatin americanpharmaceuticalreview
June 06, 2019
Windtree Therapeutics and Eleison Pharmaceuticals jointly announced positive results of the feasibility study using Windtree's proprietary Aerosol Delivery System (ADS) aerosolization technology to deliver Eleison's inhaled lipid cisplatin (ILC).
Promising early results for BMS’ investigational HCC study pharmatimes
June 05, 2019
Bristol-Myers Squibb (BMS) has announced the first results from its investigational Opdivo (nivolumab) plus Yervoy (ipilimumab) cohorts of the Phase I/II CheckMate -040 study at the American Society of Clinical Oncology (ASCO) meeting 2019.
Breast Milk Has Biggest Benefit for Preemies' Brains: Study drugs
April 28, 2019
SATURDAY, April 27, 2019 -- Another reason breast is best: Breast milk boosts levels of chemicals crucial for brain growth and development in premature babies with a very low birth weight, a new study reveals.
CRO Inks OmniComm EDC Agreement contractpharma
March 19, 2019
Will use TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the UK.
BioPlan Benchmarks the State of Biopharma Mfg. pharmafocusasia
March 14, 2019
BioPlan Associates recently launched its 16thAnnual Survey on Biopharmaceutical Manufacturing. One of the industry’s most comprehensive reports of its kind, BioPlan benchmarks current global and regional trends affecting the bio industry.
AstraZeneca, Seres in Cancer Research Tie-up contractpharma
March 13, 2019
Seres to receive $20 million and financial support for research activities

Previous page 1 2 3 4 5 Next page